Achieving treatment goals of reducing or maintaining body iron burden with deferasirox in patients with β-thalassaemia: results from the ESCALATOR study

This analysis evaluated the effects of deferasirox on liver iron concentration in moderate and heavily iron-overloaded patients with β-thalassaemia from the ESCALATOR trial (n = 231). Mean liver iron concentrations (LIC) decreased significantly from 21.1 ± 8.2 to 14.2 ± 12.1 mg Fe/g dry weight (dw)...

Descripción completa

Detalles Bibliográficos
Autores principales: Taher, Ali, Elalfy, Mohsen S, Al Zir, Kusai, Daar, Shahina, Al Jefri, Abdullah, Habr, Dany, Kriemler-Krahn, Ulrike, Roubert, Bernard, El-Beshlawy, Amal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229710/
https://www.ncbi.nlm.nih.gov/pubmed/21668501
http://dx.doi.org/10.1111/j.1600-0609.2011.01661.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229710/
https://www.ncbi.nlm.nih.gov/pubmed/21668501
http://dx.doi.org/10.1111/j.1600-0609.2011.01661.x

Ejemplares similares